[IMM-G Roster]
The Immunology Integrated Review Group (IRG) Special Emphasis Panel ZRG1 IMM-G (10) B reviews Small Business Innovation Research (SBIR) and the Small Business Technology Transfer Research (STTR) grant applications from the small business community in the area of basic immunology. Applications from small businesses which address basic and applied immunology, immunologic therapies, and diseases of immunologic origin are appropriate for review. These applications should project the development of a product, process, or service towards a commercial venture. Specific areas covered by this group:
- Antibodies: polyclonal, monoclonal, isolation, selection, characterization, development, production, processing, xenogeneic systems.
- Immunoassays and immunologic markers: reagents, development, for transplantation, for infectious diseases, for neoplastic diseases, for autoimmune diseases.
- Immunotherapeutic regimens: for transplantation, for bacterial, viral and fungal infectious diseases, for neoplastic diseases, for autoimmune diseases including allergy, asthma, diabetes, muscular sclerosis, systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, glomerulonephritis.
- Cellular immune system: reagents for identification, characterization, and modulation of B lymphocytes, T lymphocytes, dendritic cells, eosinophils, stem cells, bone marrow, lymph nodes, mast cells, antigen-presenting cells, cytotoxic cells.
- Innate immune system: reagents for identification, characterization, and modulation of complement, monocytes, macrophages, neutrophils, basophils, natural killer cells.
- Immunomodulation of the immune system interactions: suppression, enhancement, biologics including cytokines, small molecules, proteins/peptides.
IRGs with the most closely related areas of science listed in rank order are:
Infectious Diseases and Microbiology IRG
Oncology 1 - Basic Translational IRG
Oncology 2 - Translational Clinical IRG
Endocrinology, Metabolism, Nutrition, and Reproductive Sciences IRG
|
|